Gilead Sciences (GILD) EBT Margin (2009 - 2026)
Gilead Sciences (GILD) posted EBT Margin of 37.07% for Q1 2026, up 41.37% quarter-over-quarter from 26.22% in Q4 2025, and up 1234.0% year-on-year from 2.78% in Q1 2025.
Gilead Sciences (GILD) EBT Margin (2009 - 2026) Analysis & Trends
Gilead Sciences (GILD) has reported EBT Margin for 18 consecutive years, with 37.07% the latest figure, recorded in Q1 2026.
- EBT Margin for Q1 2026 came in at 37.07%, up 1234.0% year-over-year; the trailing twelve-month figure through Mar 2026 was 36.08% (up 1233.0% YoY), and the FY2025 annual result was 33.27%, up 3087.0% from the prior year.
- EBT Margin was 37.07% for Q1 2026 at Gilead Sciences, up from 26.22% in the prior quarter.
- Over five years, EBT Margin peaked at 46.87% in Q3 2025 and troughed at 67.1% in Q1 2024.
- Average EBT Margin over 5 years is 21.02%, with a median of 26.22% recorded in 2025.
- Year-over-year, EBT Margin slumped 8756 bps in 2024 and jumped 9183 bps in 2025.
- Over 5 years, EBT Margin stood at 27.49% in 2022, then declined by 15 bps to 23.24% in 2023, then increased by 23 bps to 28.63% in 2024, then retreated by 8 bps to 26.22% in 2025, then surged by 41 bps to 37.07% in 2026.
- Per Business Quant data, the three most recent EBT Margin figures were 37.07% in Q1 2026, 26.22% in Q4 2025, and 46.87% in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Margin (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,066.16 Bn | 1,060.88 Bn | 16.22 Bn | 44.70% |
| 2 | Johnson & Johnson | 611.69 Bn | 589.64 Bn | 15.96 Bn | 24.89% |
| 3 | AbbVie | 444.34 Bn | 434.99 Bn | 10.78 Bn | 6.93% |
| 4 | Astrazeneca | 284.94 Bn | 277.05 Bn | 12.61 Bn | 27.21% |
| 5 | Merck | 224.23 Bn | 218.58 Bn | 12.09 Bn | -21.49% |
| 6 | Amgen | 195.12 Bn | 183.08 Bn | 5.87 Bn | 24.18% |
| 7 | Gilead Sciences | 156.45 Bn | 148.73 Bn | 5.52 Bn | 37.07% |
| 8 | Pfizer | 136.01 Bn | 123.24 Bn | -1.21 Bn | 135.53% |
| 9 | Novartis Ag | 113.45 Bn | 113.67 Bn | - | - |
| 10 | Biogen | 30.87 Bn | 26.59 Bn | 1.82 Bn | 15.24% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 37.07% |
| Dec 31, 2025 | 26.22% |
| Sep 30, 2025 | 46.87% |
| Jun 30, 2025 | 34.30% |
| Mar 31, 2025 | 24.73% |
| Dec 31, 2024 | 28.63% |
| Sep 30, 2024 | 12.67% |
| Jun 30, 2024 | 29.52% |
| Mar 31, 2024 | -67.10% |
| Dec 31, 2023 | 23.24% |
| Sep 30, 2023 | 32.87% |
| Jun 30, 2023 | 24.06% |
| Mar 31, 2023 | 20.47% |
| Dec 31, 2022 | 27.49% |
| Sep 30, 2022 | 34.54% |
| Jun 30, 2022 | 24.01% |
| Mar 31, 2022 | -2.31% |
| Dec 31, 2021 | 10.48% |
| Sep 30, 2021 | 46.33% |
| Jun 30, 2021 | 29.23% |